HOME >> BIOLOGY >> NEWS
HPV Vaccine: What's next

Merck & Co. celebrated victory when the U.S. Food and Drug Administration advisory panel made a unanimous recommendation to the FDA to approve the first-ever vaccine to protect against women's cancer. Gardisil (quadrivalent human papillomavirus types 6, 11, 16, 18, recombinant vaccine), a vaccine developed by Merck and tested by UAB investigators, is designed to protect against human papillomavirus (HPV), the sexually transmitted virus thought to be responsible for most cervical cancers. It is being hailed as the biggest breakthrough in women's reproductive cancers since the Pap smear.

But there are still several important milestones left to conquer, says Warner Huh, M.D., gynecologic oncologist and an investigator on the Merck trials and GlaxoSmithKline's HPV vaccine clinical trials.

"The FDA advisory committee's endorsement is a major step toward protecting women from cervical cancer, and we hope to hear a final decision from the FDA by June 8," Huh said. "But more importantly, the national Advisory Committee of Immunization Practices (ACIP) will likely decide this summer whether to endorse routine vaccination with this vaccine. The ACIP's HPV vaccine workgroup is recommending vaccination for girls 11 and 12 years of age. They also will consider recommendations for older adolescents and young adults. This is the committee that will decide whether this vaccine should be part of routine vaccinations for children, like the measles, mumps and rubella or chickenpox vaccines."


'"/>

Contact: Tracy Bischoff
tracy@uab.edu
205-934-8935
University of Alabama at Birmingham
19-May-2006


Page: 1

Related biology news :

1. Whats the backscatter of your beer?
2. Whats going on in the body? Advanced time-of-flight PET takes a superior look
3. Whats in the water? Estrogenic activity documented in fish caught in Pittsburghs rivers
4. A Cross-Disciplinary Look at Scientific Truth: Whats the Law to Do?
5. Whats the difference between mice and men?
6. Ossur repeats Popular Science Best of Whats New award
7. Whats next for gene therapy? Plastic
8. Whats shaped like a pear and has two genomes? Check the pond
9. Whats nature worth? New computer models tell all
10. Anti-evolutionism in AmericaWhats ahead?
11. Ossurs Power Knee wins Popular Science magazines 2005 Best of Whats New Award

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2020)... WESTBURY, N.Y. (PRWEB) , ... April 28, 2020 ... ... clients, these webinars are Lachman Consultants latest effort in providing timely and critical ... environment, further complicated by social distancing and health safety concerns. , “Providing the ...
(Date:4/23/2020)... Wis. (PRWEB) , ... April 23, 2020 , ... ... its expansion and recruitment plans. MDG provides critical infrastructure products for the animal ... push MDG’s previous plans for expansion. Further, as supply channels from overseas competitors ...
(Date:4/18/2020)... ... April 16, 2020 , ... SIRION Biotech GmbH , ... today announced it will present a company update on its work expediting gene therapy ... taking place on April 22 and 23. Dieter Lingelbach, the Company’s Chief Operating Officer, ...
Breaking Biology News(10 mins):
(Date:5/9/2020)... (PRWEB) , ... May 08, 2020 , ... Worldwide ... of their successful business program on Sunday, May 10, 2020 and Wednesday, May 13, ... coast! This episode’s exclusive interviews will spotlight key executives from Techolution and ...
(Date:4/26/2020)... ... April 23, 2020 , ... ... an online store providing applications and services for use on Microsoft Azure. The ... needs to sign up online for a built-for-purpose customer engagement capability to use ...
(Date:4/18/2020)... ... April 17, 2020 , ... NeuroFlow ... Research (SBIR) program to support the expansion of its digital health platform enabling ... conducts a rigorous merit-based review process, adds to NeuroFlow’s recent government awards ...
(Date:4/1/2020)... GOES, Netherlands (PRWEB) , ... ... ... company, Molecular Biology Systems, B.V. (MBS) has developed a method using its ... SARS-CoV-2 to eight minutes. Combined with smaller reaction volumes, increased samples per ...
Breaking Biology Technology:
Cached News: